Servei de Pneumologia, Institut Clínic Respiratori, Hospital Clínic, Barcelona, Spain.
Department of Medical and Surgical Sciences, Institute of Respiratory Disease, University of Foggia, Foggia, Italy.
Thorax. 2017 Feb;72(2):117-121. doi: 10.1136/thoraxjnl-2016-208332. Epub 2016 Sep 1.
Some patients with COPD report frequent acute exacerbations (AECOPD) of the disease (FE), whereas others suffer them infrequently (IE). Because the current diagnosis of exacerbation relies on patient's perception of increased symptoms (mostly dyspnoea), we hypothesised that dyspnoea perception might be different in COPD patients with FE (≥2 exacerbations or 1 hospitalisation due to AECOPD in the previous year) or IE (≤1 exacerbation in the previous year), AECOPD being defined by the institution antibiotics and/or steroids treatment, or hospital admission.
To test the hypothesis that dyspnoea perception is increased in FE and/or decreased in IE with COPD.
We compared the perception of dyspnoea (Borg scale), mouth occlusion pressure 0.1 s after the onset of inspiration (P) and ventilatory response to hypercapnia (ΔV/ΔPCO) in 34 clinically stable COPD patients with FE (n=14) or IE (n=20), with similar age, gender, body mass index and degree of airflow limitation. As a reference, we studied a group of age-matched healthy volunteers (n=10) with normal spirometry.
At rest, P was higher in FE than IE and controls (p<0.01). Compared with controls, the ventilatory response to hypercapnia was equally blunted both in FE and IE (p<0.001). Despite similar spirometry, during rebreathing peak Borg score and ΔBorg were higher (p<0.01) in FE and lower (p<0.01) in IE, than in controls.
Dyspnoea perception during CO rebreathing is enhanced in FE and blunted in IE. These differences may contribute to the differential rate of reported exacerbations in FE and IE.
NCT02113839.
一些 COPD 患者报告疾病频繁急性加重(AECOPD)(FE),而另一些患者则很少发生(IE)。由于目前的加重诊断依赖于患者对症状加重的感知(主要是呼吸困难),我们假设呼吸困难的感知在 FE(≥2 次加重或上一年因 AECOPD 住院 1 次)或 IE(上一年 1 次加重)的 COPD 患者中可能不同,AECOPD 定义为机构抗生素和/或类固醇治疗或住院治疗。
检验假设,即 COPD 患者中 FE 中呼吸困难感知增加,IE 中呼吸困难感知减少。
我们比较了 34 名临床稳定的 COPD 患者中 FE(n=14)或 IE(n=20)患者的呼吸困难感知(Borg 量表)、吸气开始后 0.1s 的口腔闭塞压(P)和对高碳酸血症的通气反应(ΔV/ΔPCO),并与年龄、性别、体重指数和气流受限程度相似的健康对照组(n=10)进行比较。
在休息时,FE 患者的 P 高于 IE 患者和对照组(p<0.01)。与对照组相比,FE 和 IE 患者对高碳酸血症的通气反应同样减弱(p<0.001)。尽管肺活量测定相似,但在再呼吸过程中,FE 和 IE 患者的 Borg 峰值评分和ΔBorg 均较高(p<0.01),而对照组则较低(p<0.01)。
在 CO 再呼吸过程中,呼吸困难感知在 FE 中增强,在 IE 中减弱。这些差异可能导致 FE 和 IE 中报告的加重率不同。
NCT02113839。